Saturday, November 23, 2024
HomeTagsANSM

ANSM

Pherecydes Pharma Obtains AAC Early Access Program Approval From the ANSM for its anti-Staphylococcus aureus Phages

Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announces that it has been granted AAC...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics